Trials / Recruiting
RecruitingNCT07218705
A Study Of MCG In Cardiac Amyloidosis
A Prospective Study of Magnetocardiography for Disease Detection and Monitoring Treatment Outcomes in Amyloidosis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this observational study is to evaluate the utility of magnetocardiography (MCG) in diagnosing and monitoring disease progression in patients with amyloidosis, and to assess its effectiveness in comparison to other modalities, such as ECG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SandboxAQ CardiAQ Magnetocardiography | Magnetocardiography is a non-invasive, radiation-free imaging technique that detects the magnetic field generated by the electrical activity of the heart. |
Timeline
- Start date
- 2025-12-03
- Primary completion
- 2027-11-01
- Completion
- 2027-11-01
- First posted
- 2025-10-20
- Last updated
- 2025-12-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07218705. Inclusion in this directory is not an endorsement.